Tools

LEADER 03218nam a2200577 i 4500

001 on1482506318;

005 20241231131115.0;

006 m o d f ;

007 cr bn||||a||||;

008 241231s2024 dcu ob f000 0 eng c;

024 8 a| 56-896q| (GPO jacket number);

035 a| (Sirsi) o1482506318;

035 a| (OCoLC)1482506318;

042 a| pcc;

043 a| n-us---;

049 a| XZL4;

074 a| 1019-C-01 (online);

086 0 a| Y 4.C 73/8:117-59;

088 a| Serial no. 117-59 (United States. Congress. House. Committee on Energy and Commerce);

245 14 a| The overdose crisis :b| interagency proposal to combat illicit fentanyl- related substances : hybrid hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Seventeenth Congress, first session, December 2, 2021.;

264 1 a| Washington :b| U.S. Government Publishing Office,c| 2024.;

300 a| 1 online resource (vi, 300 pages);

336 a| textb| txt2| rdacontent;

337 a| computerb| c2| rdamedia;

338 a| online resourceb| cr2| rdacarrier;

500 a| Associated bill citation(s): H. Res. 2405.;

500 a| "Serial no. 117-59.";

504 a| Includes bibliographical references.;

511 0 a| Hearing witnesses: Kemp L. Chester, Senior Advisor, Executive Office of the President, Office of National Drug Control Policy; Nora D. Volkow, M.D., Director, National Institute on Drug Abuse, National Institutes of Health; Douglas C. Throckmorton, M.D., Deputy Director, Regulatory Programs Center for Drug Evaluation and Research, U.S. Food and Drug Administration; Louis J. Milione, Principal Deputy Administrator, U.S. Drug Enforcement Agency.;

518 a| Date of hearing: 2021-12-02.;

588 a| Description based on online resource, PDF version; title from title page (GovInfo, viewed Dec. 31, 2024).;

500 a| In scope of the U.S. Government Publishing Office Cataloging and Indexing Program (C&I) and Federal Depository Library Program (FDLP).;

650 0 a| Drug abusez| United Statesx| Prevention.=| ^A6459;

650 0 a| Drug controlz| United States.=| ^A598045;

650 7 a| Health.2| cgpa;

650 7 a| Commerce.2| cgpa;

655 7 a| Legislative hearings.2| lcgft;

776 08 i| Print version:a| United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health.t| Overdose crisisw| (OCoLC)1482506445;

856 40 u| https://purl.fdlp.gov/GPO/gpo2358747| 0;

856 4 z| Address at time of PURL creationu| https://www.govinfo.gov/content/pkg/CHRG-117hhrg56896/pdf/CHRG-117hhrg56896.pdf;

949 a| Click on web addressw| asish| joyner94;

994 a| C0b| GPO;

955 a| bca68 20241231b| 20241231;

922 a| BIBCONEWb| 20241231;

596 a| 1;

998 a| 6519213;

999 a| CLICK ON WEB ADDRESSw| ASISc| 1i| 6519213-1001l| JNETm| JOYNERr| Ys| Yt| JNE1DOu| 1/22/2025x| EDOCUMENTz| JERESOURCE;

The overdose crisis : interagency proposal to combat illicit fentanyl- related substances : hybrid hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Seventeenth Congress, first session, December 2, 2021.

Author/creator	United States
Format	Electronic
Publication	Washington : U.S. Government Publishing Office, 2024.
Description	1 online resource (vi, 300 pages)
Supplemental Content	https://purl.fdlp.gov/GPO/gpo235874
Supplemental Content	Address at time of PURL creation
Subjects	Fentanyl--Overdose. --United States. --Prevention. Xylazine--Overdose. --United States. --Prevention. Drug abuse--United States. --Prevention. Drug control--United States.

General note	Associated bill citation(s): H. Res. 2405.
General note	"Serial no. 117-59."
General note	In scope of the U.S. Government Publishing Office Cataloging and Indexing Program (C&I) and Federal Depository Library Program (FDLP).
Bibliography note	Includes bibliographical references.
Performer	Hearing witnesses: Kemp L. Chester, Senior Advisor, Executive Office of the President, Office of National Drug Control Policy; Nora D. Volkow, M.D., Director, National Institute on Drug Abuse, National Institutes of Health; Douglas C. Throckmorton, M.D., Deputy Director, Regulatory Programs Center for Drug Evaluation and Research, U.S. Food and Drug Administration; Louis J. Milione, Principal Deputy Administrator, U.S. Drug Enforcement Agency.
Date/time/place of a event note	Date of hearing: 2021-12-02.
Source of description	Description based on online resource, PDF version; title from title page (GovInfo, viewed Dec. 31, 2024).
Issued in other form	Print version: United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health. Overdose crisis
Genre/form	Legislative hearings.
Standard identifier#	56-896 (GPO jacket number)
Technical rpt number	Serial no. 117-59 (United States. Congress. House. Committee on Energy and Commerce)
GPO item number	1019-C-01 (online)
Govt. docs number	Y 4.C 73/8:117-59

Availability

Library	Location	Call Number	Status	Item Actions
	Electronic Resources	Online Content https://purl.fdlp.gov/GPO/gpo235874 Address at time of PURL creation	✔ Available

The overdose crisis : interagency proposal to combat illicit fentanyl- related substances : hybrid hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Seventeenth Congress, first session, December 2, 2021.

Click here for more information about this title

Availability